Clinical Trial Update: Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating reversal of antipsychotic-induced side effects, including hyperprolactinemia, weight gain, hyperglycemia, and dyslip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperglycemia
• Hyperprolactinemia
• Obesity

Snippet

Sponsor: Genovate Biotechnology Co., Ltd., | Conditions: Hyperprolactinemia, Weight Gain | Phase 4 | Status: UNKNOWN